These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Author: Casacchia M, Moll E.
    Journal: Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067.
    Abstract:
    Moclobemide and imipramine were compared single-blind in 2 groups of 20 depressed patients (75% and 65% endogenous depression respectively). There was no significant difference between the 2 groups in improvement on the Hamilton Rating Scale for Depression. The final overall assessment of efficacy was good or very good in 80% of the moclobemide patients and 55% on imipramine. Tolerance was good to very good in 95% of moclobemide patients, compared with 80% on imipramine. No severe adverse effects were reported in either group.
    [Abstract] [Full Text] [Related] [New Search]